Cargando…

Arenaviral vaccine vectors to combat infectious diseases

Detalles Bibliográficos
Autores principales:	Dhanwani, Rekha, Ly, Hinh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216690/ https://www.ncbi.nlm.nih.gov/pubmed/27391429 http://dx.doi.org/10.18632/oncotarget.10405

Ejemplares similares

Immunosuppressive arenaviral exoribonuclease
por: Meyer, Bjoern, et al.
Publicado: (2015)

Structures of Arenaviral Nucleoproteins with Triphosphate dsRNA Reveal a Unique Mechanism of Immune Suppression
por: Jiang, Xue, et al.
Publicado: (2013)

Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats
por: Vrba, Sophia M., et al.
Publicado: (2020)

Characterization of Chikungunya Virus Induced Host Response in a Mouse Model of Viral Myositis
por: Dhanwani, Rekha, et al.
Publicado: (2014)

Combating infectious diseases of poverty: a year on
por: Xia, Shang, et al.
Publicado: (2013)

Structure-Based Classification Defines the Discrete Conformational Classes Adopted by the Arenaviral GP1
por: Pryce, Rhys, et al.
Publicado: (2018)

Lassa Fever: Viral Replication, Disease Pathogenesis, and Host Immune Modulations
por: Ly, Hinh
Publicado: (2020)

Innate Immune Response to Arenaviral Infection: A Focus on the Highly Pathogenic New World Hemorrhagic Arenaviruses
por: Koma, Takaaki, et al.
Publicado: (2013)

Assessing the Prevalence of SARS-CoV-2 in Free-Living and Captive Animals
por: Ly, Hinh
Publicado: (2022)

Comparative Animal Models of Human Viral Infections
por: Ly, Hinh
Publicado: (2022)

BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers
por: Mustafa, Abu Salim
Publicado: (2020)

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
por: Gowen, Brian B., et al.
Publicado: (2008)

Increasing evidence of human infections by the neurotropic Borna disease virus 1 (BoDV-1)
por: Cain, Michaela, et al.
Publicado: (2023)

Vaccines for mucosal immunity to combat emerging infectious diseases.
por: van Ginkel, F W, et al.
Publicado: (2000)

Immunosuppression by hemorrhagic fever-causing viruses
por: Meyer, Bjoern, et al.
Publicado: (2015)

Immune evasion mechanisms of arenaviruses
por: Ly, Hinh, et al.
Publicado: (2015)

Viral inhibitions of PACT-induced RIG-I activation
por: Brisse, Morgan, et al.
Publicado: (2017)

Uniquely conserved immunosuppressive viral exoribonucleases
por: Meyer, Bjoern, et al.
Publicado: (2017)

Immunosuppression by viral N proteins
por: Chen, Jidang, et al.
Publicado: (2017)

Langya henipavirus: Is it a potential cause for public health concern?
por: Sanchez, Shania, et al.
Publicado: (2023)

Bioprinting for combating infectious diseases
por: Zimmerling, Amanda, et al.
Publicado: (2020)

The potential risks posed by inter- and intraspecies transmissions of monkeypox virus
por: Murphy, Hannah, et al.
Publicado: (2022)

COVID-19 evolution during the pandemic – Implications of new SARS-CoV-2 variants on disease control and public health policies
por: van Oosterhout, Cock, et al.
Publicado: (2021)

Vaccination Strategies to Combat an Infectious Globe: Oral Cholera Vaccines
por: López-Gigosos, Rosa M, et al.
Publicado: (2011)

Current view on novel vaccine technologies to combat human infectious diseases
por: Matić, Zrinka, et al.
Publicado: (2021)

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)

Epidemiological, serological, and genetic evidence of influenza D virus infection in humans: Is it a justifiable cause for concern?
por: Vega-Rodriguez, Widaliz, et al.
Publicado: (2023)

Combating Kinetoplastid diseases
por: Dávila, Alberto MR, et al.
Publicado: (2002)

Advances in microfluidics in combating infectious diseases
por: Tay, Andy, et al.
Publicado: (2016)

Trench Conflict with Combatants and Infectious Disease
por: Chorba, Terence
Publicado: (2018)

Systems thinking in combating infectious diseases
por: Xia, Shang, et al.
Publicado: (2017)

Peptides to combat viral infectious diseases
por: Al-Azzam, Shams, et al.
Publicado: (2020)

Combating the emerging viral infectious diseases
por: Jiang, Shibo, et al.
Publicado: (2015)

Combating Infectious Diseases with Synthetic Biology
por: Khan, Anooshay, et al.
Publicado: (2022)

Restricting rural-urban connect to combat infectious disease epidemic as India fights COVID-19
por: Mishra, Surabhi, et al.
Publicado: (2020)

Recent Discoveries of Novel Mammarenaviruses Infecting Humans and Other Mammals in Asia and Southeast Asia
por: Flannery, Brigitte, et al.
Publicado: (2023)

AAV Vectors Vaccines Against Infectious Diseases
por: Nieto, Karen, et al.
Publicado: (2014)

Adenovirus vector-based vaccine for infectious diseases
por: Sakurai, Fuminori, et al.
Publicado: (2022)

Next Generation Vaccines for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2019)

Vaccines against Infectious Diseases and Cancer
por: Sousa, Ângela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lud8srp7g9c9i2aqgncink6e17